Skip to main content

FDA approves Eisai's Fycompa for epilepsy


SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for epilepsy, the agency said Monday.

The FDA announced the approval of Eisai's Fycompa (perampanel) tablets to treat partial-onset seizures in patients ages 12 years and older. Partial seizures are the most common type seen in people with epilepsy, according to the FDA.

"Some people with epilepsy do not achieve satisfactory seizure control from treatments they are currently using," FDA Division of Neurology Products director Russell Katz said. "It is important to have a variety of treatment options available for patients with epilepsy."

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

This ad will auto-close in 10 seconds